New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms

Contributed by: PR Newswire

Tags

Enzymatica-AB-Study

More Like This

Interim report from clinical study: ColdZyme significantly reduces rhinovirus viral load and symptoms of sore throat

ColdZyme® certified under the new EU medical device regulation (MDR)

Nasal Spray VIRALEZE™ For Respiratory and Cold Viruses, Including New Strains

Professor Sebastian Johnston

Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials

Enzymatica AB: Invitation to Press Briefing - 5 March 2025

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG Seeks Special Approval for Cold Plasma Device for the Prevention of Ventilator-Associated Pneumonia (VAP)

Enzymatica AB - Interim report Q3/2023: Research results that reshape the competitive landscape